InvestorsHub Logo
Followers 22
Posts 3636
Boards Moderated 0
Alias Born 07/20/2006

Re: None

Wednesday, 08/26/2020 2:34:35 PM

Wednesday, August 26, 2020 2:34:35 PM

Post# of 2947
Initiating coverage - ENTA - With a current rating of Overweight, Piper Sandler initiated coverage on Enanta Pharmaceuticals Inc (NASDAQ: ENTA). The price target seems to have been set at $87.00 for Enanta Pharmaceuticals. Enanta Pharmaceuticals earned $0.71 in the third quarter, compared to $0.33 in the year-ago quarter. The stock has a 52-week-high of $73.39 and a 52-week-low of $38.40. At the end of the last trading period, Enanta Pharmaceuticals closed at $50.64.

https://finance.yahoo.com/news/benzingas-top-upgrades-downgrades-august-134200366.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News